|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-12-10
|
|
pubmed:abstractText |
This study examined patient and provider characteristics associated with being prescribed an aromatase inhibitor (AI) vs tamoxifen-only therapy among a cohort of postmenopausal North Carolina Medicaid enrollees diagnosed with hormone receptor-positive breast cancer.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0027-9684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
101
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1112-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19998639-Aged,
pubmed-meshheading:19998639-Aromatase Inhibitors,
pubmed-meshheading:19998639-Breast Neoplasms,
pubmed-meshheading:19998639-Case-Control Studies,
pubmed-meshheading:19998639-Female,
pubmed-meshheading:19998639-Healthcare Disparities,
pubmed-meshheading:19998639-Humans,
pubmed-meshheading:19998639-Logistic Models,
pubmed-meshheading:19998639-Medicaid,
pubmed-meshheading:19998639-Middle Aged,
pubmed-meshheading:19998639-Tamoxifen,
pubmed-meshheading:19998639-United States
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Patient and provider determinants associated with the prescription of adjuvant hormonal therapies following a diagnosis of breast cancer in Medicaid-enrolled patients.
|
|
pubmed:affiliation |
Division of Epidemiology, College of Public Health, Ohio State University, Columbus, Ohio, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
